Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001447028-22-000035

Options or other derivatives

  • Director acquired 41,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Torti Frank · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-05-25 Grant or award : show line 1 in the form Stock Option (Right to Buy) +41,000 41,000 D
Loading xslF345X03/wf-form4_165359607419806.xml…